Hidden Atherosclerosis Appears Early in Apparently Healthy Adults
Atherosclerosis is not waiting until middle age to begin. In a large imaging study of about 16,000 apparently healthy adults, more than half showed signs of arterial plaque, and roughly 1 in 13 people ages 18 to 29 already had detectable disease in their arteries.
The finding is difficult to ignore because plaque does not announce itself with symptoms at the start. It accumulates silently, often for years, while routine office visits and standard risk estimates suggest that a young adult is still in the clear. Direct imaging of the arteries exposed a very different reality: hidden cardiovascular disease was already present in a meaningful share of people who would not ordinarily be expected to have it.
Arterial Plaque in the First Decades of Adult Life
The age gradient is the most clinically striking part of the report. Plaque was not confined to older adults with long-standing hypertension, diabetes, or established coronary disease. It was visible even in the youngest adults included in the analysis, which means atherosclerotic change can begin far earlier than many patients assume and earlier than many clinicians may suspect when risk seems low on paper.
Atherosclerosis develops when lipid-rich material, inflammation, and vascular injury gradually alter the artery wall. Once plaque forms, the process can progress quietly until it narrows blood flow or becomes unstable enough to rupture. In practice, the disease often spends years in a subclinical phase, which is why detection at the imaging stage matters so much: it identifies vascular injury before the first heart attack or stroke forces the diagnosis.
The study’s message is not that every young adult needs advanced vascular imaging. The message is more specific and more unsettling. Apparent health and true vascular health are not always the same thing.
Why Direct Imaging Changes the Prevention Conversation
Traditional prevention often begins with age-based calculators, blood pressure checks, cholesterol testing, smoking history, and family history. Those tools remain essential, but they do not capture every person carrying early plaque. Direct imaging can reveal disease that standard risk estimation may miss, especially in people who appear too young or too low-risk to raise concern.
That matters because atherosclerosis is a cumulative process. Once plaque is present, the prevention strategy changes from trying to predict risk to trying to interrupt a disease process that has already started. For younger adults, that could sharpen attention to LDL cholesterol, blood pressure, smoking, weight, glycemic status, diet, and physical activity long before a coronary event enters the picture.
One sentence from this study carries the bedside weight: hidden plaque was already present in people in their teens and twenties. The usual assumption that vascular disease belongs to later life no longer holds.
What Hidden Plaque Means for Clinicians and Patients
The practical consequence is earlier recognition of silent disease. A young adult with no symptoms may still have arterial injury that will matter over decades, not months. When imaging identifies plaque at that stage, it can justify more intensive prevention, closer follow-up, and more serious conversations about modifiable risk.
This also complicates the idea of reassurance. Normal feelings, normal exercise tolerance, and even a normal-looking clinic visit do not necessarily rule out early atherosclerosis. The arteries can be changing long before the first clinical event. For prevention medicine, that is the central challenge: find the disease while the patient still feels well enough to ignore it.
The biology supports that urgency. Plaque formation is a slow inflammatory and lipid-driven remodeling of the vessel wall, not a sudden event. Once the process is underway, the future risk trajectory can shift upward even when the patient remains outwardly healthy. Early detection gives clinicians a chance to intervene while arterial injury is still modifiable.
Screening Questions Raised by a Younger Population With Plaque
The study raises a narrow but important screening question: who should be imaged, and when? The finding that plaque appeared in about 1 in 13 adults ages 18 to 29 suggests that risk cannot be judged only by age. Family history, cholesterol burden, blood pressure, smoking exposure, metabolic risk, and possibly other factors may help identify the younger patients most likely to harbor silent disease.
At the same time, widespread imaging of everyone would not be a trivial step. It would carry cost, access, and downstream management issues. Some patients would need treatment escalation; others might be exposed to anxiety or additional testing without immediate benefit. The study does not resolve those trade-offs, but it does strengthen the case for targeted imaging in patients whose risk profile looks deceptively mild.
The real clinical shift is conceptual. Prevention is often discussed as if cardiovascular disease emerges late and predictably. These data suggest a much earlier onset in a subset of adults, well before symptoms or conventional thresholds would trigger concern.
A Silent Disease That Demands Earlier Attention
The most important implication is simple: arterial disease can be present long before it becomes clinical disease. In a cohort of apparently healthy adults, plaque was common, and it was already visible in a nontrivial fraction of people under 30. That should alter how aggressively clinicians think about early prevention and how seriously young adults with risk factors should be evaluated.
The unanswered issue is not whether plaque exists in the young—it does. The unanswered issue is how best to identify the people who would benefit from imaging, treatment intensification, and lifelong prevention before the first event changes the course of care.